2INAMULLAH K, MUHAMMAD N, FAROOQ E,et al. Anti- inflammatory activities of Sieboldogenin from Smilax china L. : experimental and computational studies [ J ]. J Ethnophar,2009,121 ( 1 ) : 175-177.
3LI G S, JIANG W L, YUE X D,et al. Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro [ J ]. Planta Med ,2009,75 ( 14 ) : 1470-1475.
4SHU X S, GAO Z H, YANG X L. Anti-inflammatory and anti-noeiceptive activities of Smilax china L. aqueous extract [ J ]. J Ethnophar, 2006,103 ( 3 ) : 327-332.
5HUANG H L,LIU R H, SHAO F. Structural determination of two new steroidal saponins from Smilax china [ J ]. Magn Reson Chem,2009,47 (9) :741-745.
6LI Y L, GANG P, ZHANG H Z, et al. A Flavonoid gly- coside isolated from Smilax china L. rhizome in vitro anticancer effects on human cancer cell lines [ J ]. J Ethnophar,2007,113 ( 1 ) : 115-124.
8HUANG H, CHEN G, LU Z, et al. Identification of seven rnetabolites of oxyresveratrol in rat urine and bile using liquid chromatography/tandem mass spectrometry [ J ]. Biomed Chromatogr ,2010,24 ( 4 ) : 426-432.
6Krueger GG, Elewski B, Papp K, et al. Patients with pso- riasis respond to continuous open-label recombinant tu- mor necrosis factor receptor: Fc fusion protein treatment after initial incomplete response in a randomized, place- bo-controlled trial[J]. JAm AcadDermatol, 2006,54( Sup- pl 2):$112.
7Bissonnette R. Etanercept for the treatment of psoriasis [J]. Skin Therapy Lett, 2006,11 ( 1 ) : 1.
8Tyring S, Gordon KB, Poulin Y, et al. Long-term safety and efficacy of 50 mg of etanercept twice weekly in pa- tients with psoriasis[J]. Arch Dermatol, 2007, 143 (6) : 719.
9Gordon KB, Gottlieb AB, Leonardi CL, et al. Clinical re- sponse in psoriasis patients discontinued from and then re- initiated on etanercept therapy[J]. J Dermatolog Treat, 2006,17(1) :9.
